about
Structure of yellow fever virus envelope protein domain IIINMR evidence for syn-anti interconversion of a trans opened (10R)-dA adduct of benzo[a]pyrene (7S,8R)-diol (9R,10S)-epoxide in a DNA duplexSolution structure and design of dithiophosphate backbone aptamers targeting transcription factor NF-kappaBSolution structure, dynamics, and thermodynamics of the native state ensemble of the Sem-5 C-terminal SH3 domainNMR structure of the Apo-S100P proteinAptaligner: automated software for aligning pseudorandom DNA X-aptamers from next-generation sequencing dataBone marrow endothelium-targeted therapeutics for metastatic breast cancerRole of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain IIIX-aptamers: a bead-based selection method for random incorporation of druglike moieties onto next-generation aptamers for enhanced binding.NMR structural studies of thymosin α1 and β-thymosins.Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapyMorph-X-Select: Morphology-based tissue aptamer selection for ovarian cancer biomarker discoveryBlocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis.Safety evaluation of intravenously administered mono-thioated aptamer against E-selectin in mice.TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain.Thioaptamers targeting dengue virus type-2 envelope protein domain III.A Unique and Simple Approach to Improve Sensitivity in 15N-NMR Relaxation Measurements for NH₃⁺ Groups: Application to a Protein-DNA Complex.Structures of Thymosin Proteins.Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine.NMR assignments of the yellow fever virus envelope protein domain III.Developing hyperpolarized silicon particles for in vivo MRI targeting of ovarian cancer.Thioaptamer targeted discoidal microparticles increase self immunity and reduce Mycobacterium tuberculosis burden in mice.Base-pairing properties of the oxidized cytosine derivative, 5-hydroxy uracil.Investigation of chemometric instrumental transfer methods for high-resolution NMR.A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells.X-Aptamer Selection and Validation.E-selectin Targeting PEGylated-thioaptamer Prevents Breast Cancer Metastases.Development of Phosphorothioate DNA and DNA Thioaptamers.Aptamer Therapeutics in Cancer: Current and Future.1H, 13C and 15N resonance assignments of the C-terminal domain of MutY: an adenine glycosylase active on G:A mismatchesStructural similarities between MutT and the C-terminal domain of MutYAb initio base-pairing energies of an oxidized thymine product, 5-formyluracil, with standard DNA bases at the BSSE-free DFT and MP2 theory levelsAb initio base-pairing energies of uracil and 5-hydroxyuracil with standard DNA bases at the BSSE-free DFT and MP2 theory levelsDNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow InvolvementTracking Biodistribution of Myeloid-Derived Cells in Murine Models of Breast CancerX-Aptamer Technology Identifies C4A and ApoB in Blood as Potential Markers for SchizophreniaFunctional Blockade of E-Selectin in Tumor-Associated Vessels Enhances Anti-Tumor Effect of Doxorubicin in Breast CancerBioinformatics service center projects go beyond service
P50
Q24289393-4DF3C8B4-E41D-40D9-84BE-CCF4C2612CD1Q27628500-1349B668-9511-4152-8079-820C3A153705Q27640715-C994FBD0-8178-460D-898F-8A8B860E85BCQ27641214-88F4979F-869D-443D-A664-84584E06E48FQ28268276-2B2261FE-45EA-49ED-810C-EEAFA8D513C1Q30827098-3489C94A-48D5-4466-8274-3ACEC2CECF1DQ33943576-EED85C0A-973F-434F-ACBA-0FBA28C39AA4Q33962622-4E381127-BFBD-46B5-9D6C-324058C83C15Q34443595-8F3CD6B3-959E-49B1-9C63-1B8DB554AFBFQ34643679-B97BD006-DBFE-4D39-B260-3176375143DAQ36173653-54C538C5-E985-4FF3-9A08-A9939E5DCD01Q36190984-B6619F69-D3C0-400B-9D7A-DD09E2FCA6EAQ36756674-F6CB5174-1AC2-46AF-BB55-29BECF4B0EACQ37138307-ECC1D200-8B0C-416F-84DE-E3C5D1595435Q37692733-CD27D916-ECCB-4295-BE64-1C45A9C28814Q38303914-96E1C9A2-D9A2-4412-878C-66BCEB5E65BEQ38623903-63189B92-C0D4-4D5A-BC9F-F740419FB668Q38906520-3550E835-7BD2-432E-8EB8-DEAC600BF3D5Q39361317-BBC880E4-D17E-414A-AFC8-B2630E0EC7E7Q40445891-74E5B71A-FDD8-4D3D-82DD-175ED697E7FBQ41900870-0AC661E7-DE63-409B-98F4-2CEA8D0EFE84Q41990031-776437F5-24FC-4AED-A884-804F2372211BQ43067847-4CAE49FA-B781-4A18-987B-2B17A1665589Q45992801-F6B53147-5245-4E7F-9319-08EF950F8915Q47207633-BE687D6D-1032-4D16-BAA2-4EAC3838EFD9Q47899296-71011FEC-639D-4A61-A1F4-B41CAC0C4E44Q48397159-86BC7B96-7E2D-4C7B-B397-71CC156CE777Q50893422-21169218-F471-4041-943C-0C1BCEDDB62DQ52347485-A3737B88-0E5C-483C-863A-1D0544B666BBQ73094667-D91F66C4-1393-48FF-8407-98F53409420AQ73905603-3F98202F-D09B-461C-9C39-208024FE5CC5Q80482888-26AA51A1-4F19-4BAF-9E86-AA3D47B61ABEQ83191201-62B1EDF7-C739-44E7-BD3D-F5B3C0AD5005Q88050033-FCC41CA5-C361-4CC6-979A-0030B54BCDB5Q90239273-30450F18-45F3-4EE5-864E-A365B8DE4165Q90288526-58AD2829-1DE9-452C-8CB5-C46267354C0AQ90598501-3C85BF1E-B516-4BA8-9A6E-9D00EACB257FQ91707858-5F1088AE-6168-43EA-94AC-FB800B64DA2B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David E. Volk
@ast
David E. Volk
@en
David E. Volk
@es
David E. Volk
@nl
David E. Volk
@sl
type
label
David E. Volk
@ast
David E. Volk
@en
David E. Volk
@es
David E. Volk
@nl
David E. Volk
@sl
prefLabel
David E. Volk
@ast
David E. Volk
@en
David E. Volk
@es
David E. Volk
@nl
David E. Volk
@sl
P108
P106
P108
P1153
7004501270
P21
P31
P496
0000-0002-4372-6915